Midatlantic Cardiovascular Associates — Baltimore, Maryland

Midatlantic Cardiovascular Associates is a clinical research site located in Baltimore, Maryland, United States 21229.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Midatlantic Cardiovascular Associates has participated in 4 clinical trials.

Therapeutic areas: Congestive Heart Failure, Arthritis, Rheumatoid, Device Replacement.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc., Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Biotronik, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Midatlantic Cardiovascular Associates?

Midatlantic Cardiovascular Associates has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Midatlantic Cardiovascular Associates conducted?

Midatlantic Cardiovascular Associates has 4 clinical trials on record. Their work covers Congestive Heart Failure, Arthritis, Rheumatoid, Device Replacement.

Is Midatlantic Cardiovascular Associates accredited by Crixeo Health?

Yes — Midatlantic Cardiovascular Associates holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Midatlantic Cardiovascular Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.